A detailed history of Bullseye Asset Management LLC transactions in Silk Road Medical Inc stock. As of the latest transaction made, Bullseye Asset Management LLC holds 131,718 shares of SILK stock, worth $3.56 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
131,718
Previous 131,718 -0.0%
Holding current value
$3.56 Million
Previous $1.62 Million 49.32%
% of portfolio
1.13%
Previous 0.77%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$6.29 - $15.72 $125,800 - $314,400
20,000 Added 17.9%
131,718 $1.62 Million
Q3 2023

Nov 15, 2023

BUY
$14.99 - $32.65 $476,921 - $1.04 Million
31,816 Added 39.82%
111,718 $1.68 Million
Q2 2023

Aug 15, 2023

BUY
$29.76 - $46.14 $245,520 - $380,655
8,250 Added 11.51%
79,902 $2.6 Million
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $43,710 - $58,154
-1,182 Reduced 1.62%
71,652 $3.23 Million
Q2 2022

Aug 15, 2022

BUY
$28.03 - $45.8 $2,887 - $4,717
103 Added 0.14%
72,834 $2.65 Million
Q3 2021

Nov 15, 2021

SELL
$44.0 - $65.8 $16,764 - $25,069
-381 Reduced 0.52%
72,731 $4 Million
Q2 2021

Aug 13, 2021

BUY
$44.66 - $63.06 $669,900 - $945,900
15,000 Added 25.81%
73,112 $3.5 Million
Q4 2020

Feb 12, 2021

SELL
$55.51 - $69.94 $39,634 - $49,937
-714 Reduced 1.21%
58,112 $3.66 Million
Q3 2020

Nov 12, 2020

SELL
$42.19 - $69.61 $2,404 - $3,967
-57 Reduced 0.1%
58,826 $3.95 Million
Q2 2020

Aug 11, 2020

BUY
$27.55 - $43.28 $1.46 Million - $2.29 Million
52,965 Added 894.98%
58,883 $2.47 Million
Q1 2020

May 08, 2020

SELL
$23.16 - $47.8 $1,899 - $3,919
-82 Reduced 1.37%
5,918 $186,000
Q4 2019

Feb 18, 2020

BUY
$27.97 - $40.38 $167,820 - $242,280
6,000 New
6,000 $242,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.02B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Bullseye Asset Management LLC Portfolio

Follow Bullseye Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bullseye Asset Management LLC with notifications on news.